Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01393873 · ClinicalTrials.gov registry record
Progression of Diabetic Retinopathy Post Bariatric Surgery (BS)
A clinical trial, sponsored by NYU Langone Health.
- Terminated
- Registry status
- 2
- Enrollment target
NCT01393873 is a clinical trial that was terminated before completion, run by NYU Langone Health. The registered enrollment target is 2 participants.
The verdict
NCT01393873 was terminated before completion, sponsored by NYU Langone Health.
- TERMINATED
- Registry status
- 2 participants
- Enrollment target
Study Summary
Studies conducted assessing diabetic eye disease have shown a progression of diabetic retinopathy with rapid improvement of glycemic control during pregnancy and in patients with type 1 diabetes. It is also well documented that bariatric surgery may result in rapid improvement of glycemic control in obese patients with type 2 diabetes. To our knowledge the progression of diabetic eye disease seen in pregnancy and type 1 diabetes has not been studied in obese type 2 diabetics undergoing bariatric surgery. To this end, this study will examine the effects of rapid glycemic control which is seen in type 2 diabetics following bariatric surgery on the progression of diabetic retinopathy.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2011-07 |
| Est. Completion | 2012-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01393873
The ClinicalTrials.gov registry entry for NCT01393873 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01393873 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01393873 about?
NCT01393873 is a clinical study titled "Progression of Diabetic Retinopathy Post Bariatric Surgery (BS)". Studies conducted assessing diabetic eye disease have shown a progression of diabetic retinopathy with rapid improvement of glycemic control during pregnancy and in patients with type 1 diabetes. It is also well documented that bariatric surgery may result in rapid improvement of glycemic control in...
What is the current status of trial NCT01393873?
This trial is currently terminated. The enrollment target is 2 participants. The study started on 2011-07. Estimated completion is 2012-07.
Who is sponsoring clinical trial NCT01393873?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.